Drug Database
Back to search

Belgium· BE-AMP-SAM184301-00

Innohep 18000 anti-Xa U/0,9 ml

A tinzaparin product containing tinzaparin sodium, registered in Belgium by Leo Pharma. The same ATC class is registered in 9 of our 19 countries.

ATC B01AB10

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedInnohep 18000 anti-Xa U/0,9 mlATCB01AB10REGISTER NO.BE-AMP-SAM184301-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tinzaparin sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tinzaparin is registered in 9 of 19 countries.

Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search tinzaparin products by name

Tinzaparin · ATC B01AB10

9 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tinzaparin Sodium
Manufacturer
Leo Pharma
Country
Belgium (BE)
ATC code
B01AB10
ATC class
Tinzaparin
Defined daily dose
3.5 TSD, E
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    1414549
    EUR 122.04
  • be_apb
    0748863

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

162 interactions on record for tinzaparin.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tinzaparin against other medicinesHow interaction checks work

Tinzaparin · interactions on record

162 records

  • 94 severe
  • 68 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tinzaparin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tinzaparin products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Cyprus · Innohep
  • Germany · Innohep, Innohep Multi
  • Denmark · Innohep
  • Spain · Innohep
  • Finland · Innohep, Innohep®
  • France · Innohep
  • United Kingdom (Northern Ireland) · Innohep, Tinzaparin
  • Greece · Innohep
  • Ireland · Innohep
  • Italy · Innohep
  • Luxembourg · Innohep
  • Netherlands · Innohep
  • Portugal · Innohep
  • Romania · Innohep
  • Sweden · Innohep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4f70bc4-cad2-4f9e-b807-e3300a350ee7
GET /v1/drugs/d4f70bc4-cad2-4f9e-b807-e3300a350ee7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Innohep 18000 anti-Xa U/0,9 ml",
  "name_fr": "Innohep 18000 anti-Xa U/0,9 ml",
  "name_nl": "Innohep 18000 anti-Xa U/0,9 ml",
  "amp_code": "SAM184301-00",
  "strengths": [
    "10000.0000",
    "0.9200"
  ],
  "pack_count": 2,
  "substances": [
    "Tinzaparin Sodium",
    "Sodium Hydroxide",
    "Sodium Metabisulfite"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tinzaparin",
  "authorisation_numbers": [
    "BE184301"
  ]
}
API referenceMCP serverPlans

See everything about tinzaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console